Related Experiment Videos

Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood

A Marchant1, J Duchow, J P Delville

  • 1Department of Immunology, Hôpital Erasme, Université Libre de Bruxelles, Belgium.

Insights

Lipopolysaccharide (LPS) rapidly increases its own receptor, CD14, on monocytes in human blood. This LPS-induced CD14 upregulation may play a role in gram-negative sepsis pathogenesis.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Lipopolysaccharide (LPS) is a key component of gram-negative bacteria.
  • CD14 is a well-established receptor for LPS on myeloid cells.

Purpose of the Study:

  • To investigate the effect of LPS on CD14 expression in human whole blood.
  • To determine the kinetics and characteristics of LPS-induced CD14 upregulation on monocytes.

Main Methods:

  • Flow cytometry was used to analyze CD14 expression on monocytes.
  • Human whole blood was incubated with varying concentrations of LPS.

Main Results:

  • LPS induced a rapid, dose-dependent increase in monocyte CD14 expression within 30 minutes, peaking at 1-3 hours.
  • The upregulation of CD14 was not dependent on new protein synthesis.
  • Increased CD14 expression correlated with enhanced binding of fluoresceinated LPS.

Conclusions:

  • LPS upregulates its own receptor, CD14, on monocytes in whole blood.
  • This phenomenon may be significant in the pathogenesis of gram-negative sepsis.

Related Concept Videos